New drug LW402 passes early safety check in healthy volunteers
NCT ID NCT07546149
First seen Apr 26, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This early-stage study tested the safety and tolerability of multiple doses of LW402 tablets in 36 healthy volunteers. Researchers monitored side effects and how the drug moves through the body. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY EVALUATION OF ESCALATING DOSES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shangdong, China
Conditions
Explore the condition pages connected to this study.